The primary transcripts of most eukaryotic genes are not colinear with their corresponding mature mRNA transcripts. Rather, dispersed throughout the body of nuclear mRNA precursors are intervening sequences (introns) of various lengths. Intron excision is catalyzed by a complex ribonucleoprotein, the spliceosome, and progresses via a two-step reaction pathway involving (i) cleavage at the 5' splice site/intron border with concomitant ligation of the intron's 5'-terminal phosphate to a 2' hydroxyl within the branch point sequence and (ii) cleavage at the intron/3' splice site border and exon ligation (reviewed in references 13, 32, 45, and 48) .
Unlike the self-splicing group II introns, which autoexcise through an analogous pathway, the removal of nuclear introns requires the participation of numerous proteins and transacting small nuclear RNAs (snRNAs) and the consumption of an undetermined number of ATP molecules. The parallels between the autocatalytic and pre-mRNA splicing pathways and the presence of essential snRNAs within the spliceosome suggest that the spliceosomal snRNAs establish a catalytic scaffold on the pre-mRNA similar to that achieved by the internal structure of self-splicing introns (10, 13, 57) . Consistent with this view, genetic and biochemical studies have identified phylogenetically conserved interactions between the pre-mRNA 5' splice site and the Ul and U6 snRNAs (51, 52, 54, 59, 68, 71) , between the branch point sequence and the U2 snRNA (37, 68, 70, 72) , and between the exon sequences flanking the intron borders and U5 snRNA (35, 36, 68 ). An interaction between nucleotides 9 and 10 of the 5' end of Ul snRNA and the 3' splice site has been proposed for most Schizosaccharomyces pombe introns (41) , but this interaction may not be a general characteristic of intron organization (53) . Superimposed on the dynamic network of pre-mRNA/snRNA interactions are snRNA-mediated inter-snRNP contacts (e.g., U2-U6 and U4-U6) that contribute to the formation of an active spliceosome (13, 32, 45, 48) . The inferred net result of the snRNP/pre-mRNA interactions is the formation of a structure, suggested to be reminiscent of the Holliday intermediate in recombination, in which the chemically reactive nucleotides of the pre-mRNA are juxtaposed in a context favorable to splicing (reference 65 and references therein). Proteins are required for the ATP-driven assembly and function of the spliceosome, including the formation and resolution of numerous RNA-RNA contacts. It remains unknown whether amino acid residues are essential components of the spliceosome's active site(s).
The first defined step of spliceosome assembly in the yeast Saccharomyces cerevisiae involves the stable binding of Ul snRNP to the pre-mRNA through contacts at the 5' splice site and branch point regions (24, 44, 55) . This ATP-independent association, also detected in the mammalian system (30, 31) , is believed to direct the RNA substrate away from the (presumed) default path of cytoplasmic export to one of transient nuclear retention and pre-mRNA splicing (reviewed in reference 42) . The pre-mRNA/U1 snRNP commitment complex is a transient intermediate that is normally rapidly converted into the U2-containing pre-spliceosome and higher-order structures. In splicing extracts, however, pre-mRNA can be stably trapped in the commitment complex state by depleting or inactivating U2 snRNP (24, 25, 44, 55) . On native polyacrylamide gels, the commitment complex is resolved into a pair of bands, termed CC1 and CC2. A pre-mRNA 5' splice site element is required for both bands; CC2, but not CC1, requires a functional branch point sequence (56) . Although it is not yet clear if CC1 is an obligate intermediate in CC2 formation, the more slowly migrating CC2 band appears to represent a higher-order structure and likely contains the polypeptides present in CC1 and at least one additional (or newly positioned) factor mediating Ul snRNP association with the branch point region. These data are consistent with the view that 5' splice site recognition by the Ul snRNP initiates in vitro spliceosome assembly.
The architecture of the Ul snRNP/pre-mRNA interaction is largely unknown. The 5-to 7-bp association between the pre-mRNA 5' splice site and the 5 (58) . Strain ts307 (AMITox prp39-1 trpl-289 ura3-53 his3 leu2-3,112 cyhR) was isolated from an ethyl methanesulfonate-mutagenized yeast bank as a temperaturesensitive (ts) strain defective in intron excision as described previously (8) . Complementation analysis was performed by assaying for growth at 37°C diploid strains constructed through pairwise crosses of ts307 with the wild-type strain, MGD353-13D (MA Ta trpl-289 ura3-53 leu2-3,112 arg4 ade2), and the previously defined splicing mutant set (8) .
PRP39 was isolated from a YCp5O-based centromeric plasmid library (43) by complementation of the ts307 growth and splicing defects. Subcloning experiments to localize the PRP39 coding segment were performed by using the yeast transformation vectors YCplac33 and YCpLac22 (12) and the DNA sequencing vector pTZ18u (U.S. Biochemical). The 2,414-bp complementing AvaII DNA fragment was sequenced in both directions by the dideoxynucleotide method (50), using Sequenase as instructed by the manufacturer (U.S. Biochemical). Various deletion derivatives created enzymatically by the Erase-a-Base (Promega) approach were used as sequencing templates. Protein sequence comparisons were performed using the Intelligenetics Quest and FASTDB programs and the National Center for Biotechnology Information Blast programs (1) with the public GenBank, EMBL, and Swiss-Prot data bases and a personal data base collected by Mark Goebl (Indiana University) and Ewan Birney and Adrian Krainer (Cold Spring Harbor Laboratory).
Genetic analysis of the PRP39 locus. The disruption of PRP39 was accomplished by insertion of a 2.2-kbp DNA fragment containing the yeast LEU2 gene (9) into the ClaI site of the PRP39 subclone YCplac33HS (29) . The ends of vector and insert DNA were rendered blunt by using T7 exonuclease prior to joining with T4 DNA ligase. The disrupted gene, prp39::LEU2, was released from its vector sequences with HindIII and BamHI and used for transformation to replace one copy of the chromosomal PRP39 locus in diploid strain MGD407 (46) by homologous recombination. Transformants were selected on defined media lacking leucine (58) , and the correct placement of the transforming DNA at the PRP39 locus was verified by Southern blotting. The restriction fragment digestion pattern of the wild-type PRP39 locus was consistent with this locus being single copy in the haploid genome. (19) . The PRP39 DNA was purified as a PCR fragment generated with oligonucleotides corresponding to sequences at the PRP39 translational initiation codon (TATA GATCTGTTATGCCAGATGAAACAAAT) and within the 3' flanking region (T'lTAGATCTCCGAGTAAATTA'TTT TAA). Derivative GAL1::prp39A50, deleted for codons 1 to 49, was constructed similarly, using the 5' oligonucleotide (TATA GATCTCAAATGGTAGATGTTATAGAG). Each PCR oligonucleotide incorporated a noncoding BglII restriction site, which was subsequently used for cloning into the BamHI site of pBM150.
An oligonucleotide containing 27 codons corresponding to the hemagglutinin (HA) epitope (69) AvaII PRP39 subclone. This ligation replaced the normal PRP39 3' end with the PRP39HA derivative. Yeast that uniquely expressed this HA-tagged allele were genetically isolated by using YCplac22-PRP39II4 to transform a diploid strain heterozygous for the prp39::LEU2 disruption as described above. In this case, however, the meiotic offspring were screened on media that lacked leucine and tryptophan to identify cells that contained both the prp39::LEU2 disruption and the TRPJ-marked YCplac22-PRP39HIA plasmid.
In vitro spliceosome assembly and splicing assays. Yeast whole cell extracts were prepared as described previously (28) except that lyticase (165 ug/ml; Sigma) was used for spheroplast formation. Extracts depleted of Prp39p were prepared by collecting, by centrifugation, 5 ml of a log-phase GAL1::PRP39 culture grown in rich medium (YEP-2% galactose) (58) , washing the pellet once with 20 ml of glucose containing YEPD broth, and resuspending the second pellet in 1 liter of the same. The glucose cultures were grown at 30°C and maintained at an optical density at 600 nm of <0.8 until harvest by periodic dilution in fresh YEPD broth. To heat inactivate Prp39p in vivo, the ts307 spheroplasts were shifted to 37°C for 2 h prior to spheroplast formation. (39) , GUAUAU (55) (also called 5'II [18] ), or 5'-0 (38) RNA. The branch point deletion derivative, BP Del., was isolated as a spontaneous mutation and contains the sequence AGAGGCAGTTCATG substituted for nucleotides 321 to 337 of the RPSlA intron. The splicing reactions were terminated, and the products were resolved on denaturing 15% polyacrylamide gels as described elsewhere (39) .
To visualize splicing complexes, the reactions were stopped with an equal volume of R buffer (50 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES, pH 7.5], 2 mM magnesium acetate, 20 mM EDTA) and made 1 ,ug/ml with competitor RNA (total yeast RNA). The samples were then separated on a 3% polyacrylamide (60:1 acrylamide/bisacrylamide ratio)-0.5% agarose composite gel run in 0.5 x TAE buffer (49) . The gels were dried at 80°C for 1 h and autoradiographed.
To visualize the U-snRNP complexes, 5 to 8 RI of splicing extract was mixed 1:1 with R buffer, heparin (U.S. Biochemical) was added to 0.5 mg/ml, and the samples were resolved on a 4% polyacrylamide (60:1 acrylamide/bisacrylamide ratio)-0.5% agarose gel. Finally, the gel was electroblotted to a Nytran+ membrane (Schleicher & Schuell) and hybridized with snRNA-specific probes prepared as previously described (8) .
Immunoprecipitation studies. cellular product. Taken together, the simultaneous relief of the ts growth and splicing phenotypes with the complementing DNA segment, the cosegregation of the cloned DNA segment with the PRP39 locus, and the lethal nature of the genetically engineered mutations provided strong evidence that the putative 629-amino-acid (75-kDa) polypeptide is Prp39p. The deduced polypeptide structure lacks obvious similarity to known splicing factors or to consensus elements commonly found in nucleic acid-binding proteins (e.g., RNA recognition motifs and zinc finger sequences).
The genetic studies described above showed that mutant alleles of PRP39 inhibited pre-mRNA splicing and decreased cell viability. As a tool to investigate the function of native Prp39p, we created an new allele in which the natural PRP39 transcriptional regulatory sequences were replaced by those of the galactose-inducible, glucose-repressible GALI gene. When cells expressed GAL1::PRP39 as their sole source of Prp39p, pre-mRNA splicing and hence cell growth became galactose dependent (Fig. 3A) . Decreased splicing efficiency, as evidenced by increased RPSlA pre-mRNA levels, was obvious 12 h after glucose repression; cell division essentially ceased 10 (Fig. 4,  lanes 5 and 6) . No block to splicing complex formation resulted from like heat treatment of wild-type extracts (lanes 1 and 2) . Extracts prepared from prp39-1 cultures temperature inactivated in vivo or from glucose-repressed GAL1::PRP39 cultures also failed to support prespliceosome assembly (lanes 9 and 11).
Inactivation of U2 snRNA in wild-type extracts by an oligonucleotide-directed RNase H cleavage blocked U2 addition and allowed visualization of the Ul-bound pre-mRNA commitment complex bands in both wild-type and prp39-1 extracts (Fig. 4, lanes 3 and 7) . These bands were absent, however, if ts Prp39p was heat-inactivated in vitro (lane 8) or in vivo (lane 10) or if the extract was metabolically depleted of Prp39p (lane 12). The failure to assemble CC1 and CC2 after Prp39p inactivation or removal was independent of the RNase H-mediated degradation of U2; no complexes were observed in the absence of this pretreatment (lanes 6, 9, and 11). In addition to the predicted gel complexes, a band of variable intensity, N, was observed with all extracts, independent of splicing competence. The origin of N is unknown; however, non-specific RNA-protein complexes are commonly observed in this assay (for example, see native gel figures in references 11 and 25). In any case, the absence of the CC1 band in all Prp39p-deficient extracts suggested that Prp39p functioned prior to branch point recognition by the Ul snRNP (i.e., the CC2 band), at the step of stable Ul snRNP/5' splice site interaction.
A substrate challenge approach has been described to monitor yeast pre-mRNA/U1 snRNP interaction in solution (24) . In this assay, the splicing substrate is first preincubated in an ATP-free and U2 snRNP-inactivated extract to promote the Ul snRNP/pre-mRNA interaction. Then, the committed substrate is presented with complete splicing extract containing ATP, U2 snRNP, and an excess of competing pre-mRNA, and splicing is monitored. When this functional assay was applied to extracts in which Prp39p activity had been removed in vivo by temperature inactivation or by metabolic depletion, no splicing was observed (29a). This observation is consistent with the observed block to the formation of CC1 and CC2 and argues strongly that Prp39p-deficient extracts lack the capacity to sequester exogenously added pre-mRNA in a functional Ul snRNP complex. Ul snRNP particles contain Prp39p. The Prp39p dependence of CC1 formation could be explained if Prp39p was an essential component of the Ul snRNP. To address this possibility, a derivative of PRP39 was created to add sequences coding for the nine-amino-acid HA epitope (69) after the penultimate PRP39 codon. Western blots (immunoblots) probed with HA-specific monoclonal antibody 12CA5 showed that a polypeptide with an apparent molecular mass slightly less (65 versus 75 kDa) than that predicted for Prp39p expressed from its putative translational initiation codon was uniquely present in cells with the PRP39HA gene fusion (data not shown). In vivo, PRP39IHA was functional; it fully complemented the ts prp39-1 mutation and the prp39::LEU2 null mutation. To determine whether any spliceosomal snRNAs were associated with Prp39HA, RNAs coprecipitated with antibody 12CA5 were analyzed by Northern blotting (Fig. 5) . Ul snRNA was found in the immune pellet of the Prp39HA extract but not in the Prp39p control extract (Fig. 5, lanes 2 and  3) . The (29) . This result suggested that the unbound Ul snRNA was present in a distinct snRNP population, one not associated with Prp39HA or one in which the HA epitope was obscured. We favor the former interpretation, as Western blot analysis showed that all of the detectable Prp39HA could be recovered by immunoprecipitation (data not shown), and native gel studies identified a Ul snRNA subpopulation present in an incomplete snRNP complex (see below).
The affinity of Prp39HA for the Ul snRNP was evaluated by repeating the 12CA5 immunoprecipitation at increased salt concentrations (Fig. 5, lanes 7 to 12) . Above (55) ; N indicates the position of a band of unknown origin present in all extracts assayed.
precipitation of the yeast Ul snRNP to at least 200 mM NaCl (27) . In light of this result, the salt-sensitive Ul snRNA coprecipitation with Prp39HA most likely reflects a comparatively weak Prp39HA/U1 snRNP interaction and not poor binding of antibody 12CA5 under these conditions. The association of Prp39p with the Ul snRNP was also examined by analyzing the migration of the spliceosomal snRNPs in the presence or absence of this polypeptide (Fig. 6A to E). Extracts prepared from PRP39 (WT) and GALI::PRP39 cultures before and after glucose repression were resolved by native gel electrophoresis, transferred to a nylon membrane, and then probed for the individual snRNAs. The mobility of the Ul snRNP was identical in the galactose-grown PRP39 and GAL1::PRP39 samples (arrow in Fig. 6A ). In contrast, the band corresponding to the Ul snRNP was greatly reduced after 12 h GAL1::PRP39 transcriptional repression and virtually undetectable after 24 h of repression (Fig. 6A) . In agreement with the observed stability of Ul snRNA during glucose repression ( Fig. 3B and data not shown), no decrease in the Ul snRNA signal was seen. Rather, the Ul snRNA migrated more rapidly after glucose repression and localized to a position just above the unassembled Ul snRNA (asterisk in Fig. 6A ). The electrophoretic mobilities of the U2, U4, U5, and U6 snRNAcontaining snRNP complexes were unaffected by Prp39p depletion ( Fig. 6B to E) . In a complementary set of experiments, antibody 12CA5 was mixed with the splicing extracts prior to snRNP resolution ( In lanes 1 to 6, extracts prepared from wild-type culture or cultures expressing the Prp39HA fusion peptide were immunoprecipitated at 50 mM NaCl with anti-HA antibody (12CA5), anti-TMG antibody (Anti-TMG), or the nonspecific control antibody Ab63 (Nonspecific Ab). After extensive washing, the immune pellets were deproteinated and the coprecipitating RNAs were analyzed by Northern blotting with probes specific for the indicated spliceosomal snRNAs. In lanes 7 to 12, immunoprecipitation was performed as described in for lanes 1 to 6 except that the salt concentration was varied in the initial precipitation step. Total, total yeast RNA.
6F and G). The Ul snRNP of the Prp39HA extract was shifted to lower electrophoretic mobility by antibody 12CA5, indicative of the increased snRNP mass (and altered structure) after antibody association. In agreement with the fact that only 40 to 70% of the Ul snRNA coprecipitated with Prp39HA, approximately one-half of the Ul signal was shifted: all of the signal within the identified Ul snRNP (Fig. 6F) and none of the signal from the more rapidly migrating and presumably incompletely assembled forms present in this extract (Fig. 6F , lower two bands). The Ul snRNP was not shifted if the HA epitope was missing or if a nonspecific control antibody (Ab63) was used (Fig. 6F) , and no other snRNP complexes were affected by 12CA5 addition (Fig. 6G and data not shown) .
Prp39p is recruited with Ul snRNP into splicing complexes. The experiments presented above showed that Prp39p is a component of the Ul snRNP and is required for CC1 formation. To determine whether Prp39p was actually present in splicing complexes, we examined the association of Prp39HA with radiolabeled RPSJA-derived pre-mRNA. Throughout a time course of in vitro splicing, pre-mRNA, but not splicing intermediate or products, was coprecipitated with antibody 12CA5 (Fig. 7 , lanes 4 to 6; a threefold-increased exposure of 12CAM precipitated pre-mRNA likewise failed to reveal splicing intermediates or products [data not shown]). This result suggested that Prp39HA was incorporated into the splicing complex but was lost (or its epitope masked) prior to the first step in splicing. The amount of pre-mRNA precipitated remained constant during the splicing time course, in agreement with the early recruitment of the Ul snRNP. In contrast, the anti-TMG antibody precipitated all substrate-derived RNA species other than mRNA (lanes 10 to 12). The amount of the anti-TMG-precipitated pre-RNA increased over time, consistent with more efficient spliceosome recovery after U4/U6/U5 tri-snRNP addition. Only background levels of pre-mRNA were recovered from immunoprecipitates performed with control antibody Ab63 (lanes 7 to 9) and from extracts that lacked the HA-tagged Prp39 polypeptide (data not shown). Although the identity of the Prp39p-associated splicing complex has not been determined, the rapid appearance and stable abundance of precipitable pre-mRNA and the virtually undetectable amount of CC1 and CC2 present under these conditions are compatible with Prp39p binding (at least) the prespliceosome. In concordance with Prp39HA associated with pre-mRNA through the Ut snRNP, 12CA5-mediated coprecipitation was greatly decreased by deletion of the 5' splice site (Fig. 7, Given that Prp39p is an essential polypeptide and that most of the yeast-specific regions of the Ul snRNA are dispensable (26, 60) , Prp39p probably associates with conserved regions of the snRNA or polypeptides bound to these conserved regions. However, Prp39p does not resemble any of the three polypeptides that uniquely copurify with the metazoan snRNP, i.e., U1-A (61), U1-C (62), and 70k (64, 67) . The yeast equivalents of U1-A (Mudl) (27) and U1-70k (Snpl) (20, 63) have been described. Curiously, while SNPI mutations are growth inhibitory or lethal (63) , MUD] (i.e., Ul-A) null mutations do not significantly inhibit cell growth or splicing (27) . An auxiliary or supplemental role for yeast U1-A in stabilizing Ut snRNA secondary structure is envisioned, as Mudl becomes essential only after significant mutational lesions are introduced into the Ul snRNA molecule (27) . To date, Prp39p is the only Ul snRNP polypeptide demonstrated to be independently essential for Ul snRNP/5' splice site interaction.
At this time, we do not know whether Prp39p binds directly to Ul snRNA. Unlike the sequence-specific RNA-binding proteins Ul-A (Mudl) and U1-70k (Snpl), yeast Prp39p and metazoan U1-C lack RNA recognition motif consensus elements (4, 40) and may function in splice site selection mainly through protein contacts (2, 14, 17, 21, 34) . A zinc finger-like structure within U1-C is required for its metazoan Ul snRNP association, although its target, whether RNA or protein, is not known (34) . The lack of similarity between Prp39p and any known RNA-binding protein and its salt-sensitive association with the Ul snRNP are consistent with protein-protein contacts mediating its Ul snRNP association. In agreement with Prp39p not being an tight, integral component of the snRNP, micrococcal nuclease-treated extracts can complement heatinactivated Prp39p. Thus, under standard splicing conditions, Prp39p can be recruited into Ul snRNP particles to replace (perhaps displace) the heat-denatured polypeptide. A functional parallel between metazoan U1-C and yeast Prp39p may exist. Human Ul snRNPs that lack U1-C bind less well to pre-mRNA splicing substrates (17) , although the reduction in pre-mRNA binding associated with U1-C removal is much less complete than that noted for yeast snRNPs deficient in Prp39p. Thus, while Prp39p does not resemble U1-C in structure, these polypeptides may be related in their organization and function within the Ul snRNP particle. Recent improvements in snRNP purification have led to the identification of numerous polypeptides associating with the U2, U5, and U4/U6/U5 snRNPs, some of which show salt-sensitive binding properties similar to those of Prp39p (3, 5, 6 (56) ; the thick horizontal line represents the intron. To highlight its proposed role in Ul snRNP function, Prp39p is diagrammed as touching the 5' splice site region of the intron. Alternatively, Prp39p may stabilize the Ut snRNP/pre-mRNA interaction indirectly through imposed conformational changes transmitted by other components of the snRNP particle.
polypeptides that associate with the putative mammalian commitment complex (E complex) (31) .
A model of Prp39p function. Mutations and chemical lesions to different nucleotides of the yeast 5' splice site can affect distinct stages of spliceosome assembly and splicing, suggestive of multiple functions for the 5' splice site (reviewed in reference 48) . A growing body of evidence supports the view that the Ul snRNP is normally repositioned or perhaps displaced from the spliceosome after the initial 5' splice site recognition event. For instance, proportionately less Ul snRNA is isolated from the mammalian spliceosome than from the E commitment complex (7, 30, 31) , in agreement with the observed decrease in Ul snRNA/pre-mRNA cross-linking after U4/ U6/U5 tri-snRNP addition (68) . Indeed, genetic (mutational suppression) and biochemical (nucleic acid cross-linking) studies show that the U5 and U6 snRNAs also interact with sequences at or very near the 5' splice site in both S. cerevisiae and mammals (35, 36, 51, 52, 54, 59, 68, 71) . As shown in this study and illustrated in Fig. 8 , yeast Prp39p is needed to establish a productive Ul snRNP/5' splice site interaction. While proof will require additional studies, it is interesting to speculate that the comparatively weak Prp39p/U1 snRNP interaction is disrupted by a component of the mature spliceosome, possibly a US or U6 snRNP polypeptide. Dissociation of Prp39p (and associated polypeptides?) might then permit the Ul snRNP particle to be released to participate in another round of spliceosome assembly. This model makes several testable predictions (e.g., an intracellular pool of free Prp39p and a subset of Ul snRNPs that lack Prp39p) that are currently under study.
